Key Dates

Related Announcements

PAR-21-156 - The Midlife in the United States Study (U19 Clinical Trial Not Allowed)

Issued by

National Institute on Aging (NIA)

Purpose

This notice informs potential applicants of changes to the Key Dates and Application Types Allowed for Funding Opportunity Announcement (FOA) PAR-21-156 “The Midlife in the United States Study (U19 Clinical Trial Not Allowed).” NIA is adding a receipt date of August 16, 2021 and changing the November 18, 2021 receipt date to February 1, 2022. NIA will also accept renewal applications for PAR-21-156.

The following Sections of PAR-21-156 have been modified:

Currently Reads:

Part 1. Overview Information

Key Dates

Letter of Intent Due Date(s): March 26, 2021 and October 18, 2021

Application Due Date(s): April 26, 2021 and November 18, 2021

Scientific Merit Review: June/July 2021; February/March 2022

Advisory Council Review: August 2021; May 2022

Earliest Start Date: September 2021; July 2022

Expiration Date: November 19, 2021

Part 2. Full Text of Announcement

Section II. Award Information

Application Types Allowed: New, Resubmission, Revision

Modified to Read (changes shown in bold italics):

Part 1. Overview Information

Key Dates

Letter of Intent Due Date(s): March 26; July 16, 2021; and January 1, 2022

Application Due Date(s): April 26, 2021; August 16, 2021; and February 1, 2022

Scientific Merit Review: June/July 2021; October/November 2021; and June/July 2022

Advisory Council Review: August 2021; January 2022; and August 2022

Earliest Start Date: September 2021; April 2022; and September 2022

Expiration Date: February 2, 2022

Part 2. Full Text of Announcement

Section II. Award Information

Application Types Allowed: New, Resubmission, Revision, Renewal

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Dana Jeffrey Plude, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-3136
Email: dana.plude@nih.gov